In a statement this week directed at the Centers for Medicare and Medicaid Services, the Leapfrog Group urged the federal agency to nix a proposal that would put an end to the public reporting of data on medical and surgical complications.

Medicare beneficiaries are expected to see lower Part B premiums in 2023 due to the lower price of Alzheimer’s drug, Aduholm. Today, Department of Health and Human Services Secretary Xavier Becerra said 2002 Medicare Part B premiums should be adjusted downward due to the drug manufacturer reducing the price of Aduholm from $56,000 per year […]